The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
GSK US Twitter
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) may be more common than you may think. #CRSwNP is often characterized by raised eosinophil levels in the nasal passages, associated with soft tissue growth, which can cause nasal obstruction, loss of smell and more.about 3 hours ago
The answer to yesterday’s poll on the prevalence of recurrent Chronic Rhinosinusitis w/ Nasal Polyps post surgery is B. 40% of people who undergo surgery for Chronic Rhinosinusitis w/ Nasal Polyps experience recurrent Nasal Polyps often requiring additional surgery. #CRSwNPabout 1 day ago
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.